According to a new analysis by Growth Plus Reports, the global patient blood management market is estimated to be worth US$ 21.64 billion by 2031, with a revenue CAGR of 5.90%. The study examines the important strategies, factors, opportunities, competitive landscape, industry patterns, market size, financial information and forecasts, and potential business opportunities.
- The increasing number of road accidents will drive market growth.
- The growth in the prevalence of hemophilia B, anemia, lymphoma, HIV/AIDS, and chronic liver problems will support market revenue growth.
- Asia Pacific will dominate the global market with the largest revenue share.
Request a Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/patient-blood-management-market/8456
Patient Blood Management Market Scope
Market size value in 2022
US$ 12.91 billion
Revenue forecast in 2031
US$ 21.64 billion
|CAGR of 5.9% from 2023 to 2031|
Base year for estimation
Product, Components, End-user, and Region.
North America, Europe, Asia Pacific, and the Rest of the World (ROW)
A rise in injuries and accidents resulting in blood loss is the primary factor driving the revenue growth of the patient blood management market. Furthermore, an increase in disease prevalence, an aging population, an increase in hemophilia B, anemia, lymphoma, and HIV/AIDS that require blood, and an increase in chronic liver problems that require plasma derivatives for treatment are expected to contribute to market revenue growth. Besides this, technological advancements, an increase in the rate of trauma and accidents, and an increase in government initiatives will boost market revenue growth.
Growth Plus Reports has analyzed the global patient blood management market from four perspectives: Product, Components, End-user, and Region.
Product Segmentation: Based on the product, the patient blood management market is segmented into instruments, reagents & kits, accessories, and software. The instruments segment dominates the market with the largest revenue share because of technological advancements, adaptability, effectiveness, dependability, and therapeutic benefits.
Components Segmentation: Based on the components, the patient blood management market is segmented into whole blood and, red blood cells, plasma. The whole blood segment dominates the market with the largest revenue share because of the rising number of road accidents.
End-User Segmentation: Based on the end-user, the patient blood management market is segmented into blood banks, hospitals, diagnostic clinics, and pathology labs. The blood bank segment dominates the market with the largest revenue share because of the rise in orthopedic disorders and the geriatric population.
Regional Growth Dynamics
Based on the region, the global patient blood management market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
Asia Pacific dominates the global patient blood management market with the largest revenue share. Increased prevalence of specific diseases such as HIV/AIDS and TB, growth in the number of hospitals, an increase in the senior population sensitive to blood disorders such as anemia, and an increase in the purchasing power of populous countries such as China and India are the major factors responsible for Asia Pacific’s significant revenue share in the global market.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/patient-blood-management-market/8456
The important players in the global patient blood management market are:
- Asahi Kasei Corporation
- B. Braun SE
- Abbott Laboratories
- BioMérieux, Inc.
- Grifols, S.A
- Bio-Rad Laboratories, Inc.
- Haemonetics Corporation
- Haier Biomedical
- Immucor, Inc.
- LivaNova PLC
- Terumo Corporation
- Kaneka Corporation
- F. Hoffmann-La Roche Ltd.
There is moderate competition in the patient blood management market. To introduce novel drugs and products, the major players in the market emphasize research and development. Major companies often engage in mergers and acquisitions to enhance their market share.
- Grifols, a global leader in plasma medicines, announced a long-term agreement with Canadian Blood Services, Canada’s national blood authority, on September 7, 2022. This deal would greatly improve Canada’s self-sufficiency in immunoglobulin (Ig) medications and major plasma-protein therapies to address numerous immunodeficiencies and other health concerns.
- The US government awarded Terumo Corporation a US$ 10.6 million contract in April 2022 to continue its freeze-dried plasma (FDP) work.
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8456
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- ‘Business Profile’ of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at – https://www.growthplusreports.com/report-store
Browse related reports:
Gene Therapy Market by Vector Type (Viral, Non-Viral), Delivery Type (Ex-Vivo, In-Vivo), Application (Oncology, Cardiology, Neurology), End-user (Hospitals, Ambulatory Centers)– Global Outlook & Forecast 2022-2030
Digital Radiography Market by Product (Computed Radiography, Direct Digital Radiography), by Type (Dynamic, Static), by Application (General, Dentistry, Oncology, Orthopedic) – Global Outlook & Forecast 2022-2030
Medical Illumination Systems Market by Product Type (Surgical Lights, Specialty Light), by Technology (Halogen Lights, LED lights) by End User (Specialty Centers, Hospitals & Clinics) – Global Outlook & Forecast 2022-2030
Global Infectious Disease Diagnostics Market by Product (Instruments, Reagents), Technology (PCR, Immunodiagnostics), Disease Type (Hepatitis, HPV), End User (Hospitals & Clinics) – Global Outlook & Forecast 2022-2030
Medical Clothing Market by Product (Surgical Drapes, Scrubs & Gowns, Gloves, Facial Protection, Sterilization Wraps), Usage (Disposable, Reusable), End user (Hospitals, Outpatient Facilities, Home Care) – Global Outlook & Forecast 2022-2030
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.
Director, Market Insights
256 Chapman Road
STE 105-4, Newark,
New Castle – 19702, USA
Phone no: +1 888 550 5009